glp 1 drugs contraindications Diabetes mellitus: GLP-1 A number of drugs to treat diabetes mellitus have become available in recent years. Much research has focused around the role of glucagon-like peptide-1 (GLP-1), a hormone Glucagon-like Receptor-1 agonists for obesity:

In addition to NAION, Wegovy patients may also face temporary blurred vision from fluctuating blood sugar levels, an increase in eye infections, and other vision issues

[DOI] [PubMed] [Google Scholar] 45.FDA Approves Dulaglutide for Adults With T2D, Regardless of CVD

(70) demonstrated that treatment with GIPRA led to dose-dependent reductions in body weight in both wild-type and GLP-1R knockout mice, and this effect was negated by co-administration of a GIPR antagonist

[Google Scholar] 36

Furthermore, long-term studies focusing on safety, efficacy, and patient-specific factors will be essential to translate these innovations into viable therapeutic options

Sattar et al., 2021